We manage the entire pipeline from initial biomarker discovery and pilot validation to the stratification of large-scale research cohorts for analysis.
Creative Biolabs provides a robust analytical platform for mapping the molecular and cellular transitions of distant organs during the pre-metastatic phase. Our service includes exosomal profiling, spatial transcriptomics, and multi-parameter flow cytometry to characterize the "soil" of future metastatic sites. By utilizing our platform, clients gain a deeper understanding of the mechanisms of organ-specific homing and the effectiveness of niche-targeted inhibitors. This allows for the identification of high-potential research leads and the validation of early-intervention strategies in pre-clinical discovery.
The Pre-Metastatic Niche (PMN) is a systemic phenomenon where primary tumors precondition distant organs for colonization. Established research defines the PMN through characteristics such as immunosuppression, vascular permeability, and ECM remodeling. Modern breakthroughs underscore that the PMN is highly heterogeneous and influenced by the gut-microbiota axis. Creative Biolabs' service leverages these insights to provide a high-resolution map of metastatic "soil" maturity for research applications.
Fig.1 Landscape of pre-metastatic niche in various metastatic organs. 1
We manage the entire pipeline from initial biomarker discovery and pilot validation to the stratification of large-scale research cohorts for analysis.
Our experts design specialized panels for target organs like the brain, liver, or lung, incorporating niche-specific metabolic and microbial axis investigations.
Utilizing automated platforms, we process hundreds of research samples simultaneously to maintain high purity levels while significantly accelerating your project timelines.
Our platform employs Quality-by-Design principles to ensure the delivery of consistent, reproducible data across all spatial transcriptomic and proteomic analysis phases.
Creative Biolabs leads the field of microenvironment research with significant tenure and extensive industry experience, delivering dependable and professional support for all complex research projects.
We integrate established scientific principles with recent breakthroughs in environmental diversity and the gut-microbiota axis to provide cutting-edge insights for your research.
Our specialized platform employs proprietary intelligent modeling to convert biological markers into reliable probabilities, helping to accelerate your discovery and validation pipeline.
We provide advanced capabilities for mapping environmental changes, ensuring your research team can pinpoint the most high-value targets with remarkable accuracy and confidence.
Our dedicated team is standing by to help you translate complex biological signals into actionable drug discovery milestones. - Get a Quote Today
This service is most effective during target discovery and pre-clinical validation phases to demonstrate how your compound prevents organ priming before physical colonization occurs in models.
Standard methods often analyze isolated markers, whereas our AI integrates complex longitudinal data across multiple biological pillars to generate a single, validated receptivity score for research.
We offer high-resolution mapping of metabolic heterogeneity within tissue sections to identify localized metabolic shifts that drive early-stage metastatic site development.
Learn More →We provide comprehensive sequencing to identify specific microbial signatures within metastatic sites, revealing how local bacterial communities influence tumor colonization and immune evasion.
Learn More →Creative Biolabs provides a leading solution for organizations seeking to master the complexities of tumor metastasis in a research setting. By combining expertise in TME with modern technology like microbial axis profiling and AI-driven analytics, we provide the biological intelligence required to study the spread of cancer.
Whether you need to refine your experimental design, select the most relevant animal models for organotropic studies, or interpret complex multi-omic datasets, our team is available.
Reference